Discontinued — last reported Q3 '24
Idexx Laboratories LPD — Operating Income (Loss) decreased by 40.7% to $889.00K in Q3 2024 compared to the prior quarter. Year-over-year, this metric declined by 63.0%, from $2.41M to $889.00K. Over 2 years (FY 2021 to FY 2023), LPD — Operating Income (Loss) shows a downward trend with a -41.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates improved operational efficiency or higher margins within the livestock diagnostics business, while a decrease suggests rising costs or weakening demand for these specific veterinary products.
This metric represents the profitability of the Livestock and Poultry Diagnostics segment after accounting for all direc...
Comparable to segment-level operating income reported by other life sciences or animal health companies with diversified diagnostic divisions.
idxx_segment_lpd_operating_income_loss| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.87M | $3.60M | $4.36M | $6.74M | $3.23M | $4.48M | $5.36M | $1.31M | $1.95M | $2.41M | $4.31M | $866.00K | $1.50M | $889.00K |
| QoQ Change | — | -47.6% | +21.1% | +54.5% | -52.1% | +38.7% | +19.7% | -75.6% | +49.2% | +23.3% | +79.3% | -79.9% | +73.1% | -40.7% |
| YoY Change | — | — | — | — | -53.0% | +24.4% | +23.0% | -80.6% | -39.6% | -46.3% | -19.6% | -33.8% | -23.2% | -63.0% |